Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-06-20
2006-06-20
Saeed, Kamal A. (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07064206
ABSTRACT:
The present invention relates to novel, highly lipophilic silatecan intermediates and prodrugs of DB-67 and other silatecans.
REFERENCES:
patent: 5552156 (1996-09-01), Burke
patent: 5736156 (1998-04-01), Burke
patent: 6136978 (2000-10-01), Curran et al.
patent: 6207832 (2001-03-01), Curran et al.
patent: 6291676 (2001-09-01), Burke et al.
patent: 6376676 (2002-04-01), Curran et al.
patent: 6410731 (2002-06-01), Currant et al.
patent: 6743917 (2004-06-01), Curran et al.
Josien, H. 7-Silylcamptothecins (Silatecans): A New Family of Camptothecin Antitumor Agents, Bioorg. Med. Chem. Lett. 7(24), pp. 3189-3194 (1997).
Liu, X. A Versatile Prodrug Approach for Liposomal Core-Loading of Water-Insoluble Camptothecin Anticancer Drugs, J. Amer. Chem. Soc., 124, pp. 7650-7651 (2002).
Josien, H., et al., Bioorganic & Medicinal Chemistry Letters, vol. 7, pp. 3189-3194 (1997).
Liu, Xinli et al., A Versatile Prodrug Approach for Liposomal Core-Loading of Water-Insoluble Camptothecin Anticancer Drugs; J. Am. Chem. Soc.; Jan. 16, 2002, 124, 7650-7651.
Curran, D.P. Liu, H.; Josien, H; Ko, S.B., Tandem Radical Reactions of Isonitriles with 2-Pyridonyl and other aryl radicals: Scope and Limitations, and a First Generation Synthesis of (+/−)-Camptothecin, Tetrahedron, 52, 11385-11404 (1996). Published Aug. 1996.
Palmisano, F. et al., Determination of Methotrexate in Untreated Body Fluids by Micellar Liquid Chromatography, Anal. Chem., May 1989, (61) 946-950.
Pinnaduwage, P. et al. Stable Target-Sensitive Immunoliposomes, Biochemistry, 32, pp. 2850-2855 1992.
Mi, Z. and Burke, T.G., Differential Interactions of Camptothecin Lactone and Carboxylate Forms with Human Blood Components, Biochemistry, 33, 10325-10336 (1994).
Mi, Z. and Burke, T.G., Marked Interspecies Variations Concerning the Interactions of Camptothecin with Serum Albumins: A Frequency-Domain Fluorescence Spectroscopic Study, Biochemistry, 33, 12540-12545 (1994).
Mi, Z. et al., Reduced Albumin Binding Promotes the Stability and Activity of Topotecan in Human Blood, Biochemistry, 34, 13722-13727 (1995).
Josien, H. et al., 7-Silylcamptothecins (Silatecans): A New Family of Camptothecin Antitumor Agents, Bioorg. Med. Chem. Lett. vol. 7, No. 24, 3189-3295 (1997).
Josien, H. et al., A General Synthetic Approach to the (20S)-Camptothecin Family of Antitumor Agents by a Regiocontrolled Cascade Radical Cyclization of Aryl Isonitrites, Chem. Eur. J. 4, 67-83 (1998).
Curran, D.P. et al., New 4+1 Radical Annulations: A Formal Total Synthesis of (+/−)-Camptothecin, J. Am. Chem. Soc., 114, 5863-5864 (1992).
Burke, T. et al., Liposomal Stabilization of Camptothecin's Lactone Ring, J. Am. Chem. Soc., 114, 8318-8319 (1992).
Margali, R. et al., Liposomal Drug Delivery: Thermodynamic and Chemical Kinetic Considerations, J. Controlled Release, vol. 17, 285-296 (1991).
Akhtar, et al., Liposome delivery of Antisense Oligonucleotides: Adsorption and Efflux characteristics of Phosphorothioate Oligodeoxynucleotides, J. Controlled Release 22 (1992) 47-56.
Hong, C. et al., Nucleoside Conjugates. 11. Synthesis and Antitumor Activity of 1- -D-Arabinofuranosylcytosine and Cytidine Conjugates of Thioether Lipids, J. Med. Chem., 1990, 33, 1380-1386.
Burke, T.G. et al., The Structural Basis of Camptothecin Interactions with Human Serum Albumin: Impact on Drug Stability, J. Med. Chem., 37, 40-46 (1994).
Bom, D. et al., Novel A,B,E-Ring-Modified Camptothecins Displaying High Lipophilicity and Marked Improved Human Blood Stabilities, J. Med. Chem. 42, 3018-3022, 1999.
Killion, J. et al., Augmentation of Antiproliferative Activity of Interferon Alfa Against Human Bladder Tumor Cell Lines by Encapsulation of Interferon Alfa Within Liposomes, J. Natl. Cancer Inst. 81, 1387-1392 (1989).
Rahman, A. et al., Anti-Laminin Receptor Antibody Targeting of Liposomes with Encapsulated Doxorubicin to Human Breast Cancer Cells in Vitro, J. Natl. Cancer Inst. 81, 1794-1800 (1989).
Burris, H. et al. Activity of Topotecan, a New Topoisinerase I Inhibitor, Against Human Tumor Colony-Forming Units In Vitro, J. Natl. Cancer Inst. 84, 1816-1820 (1992).
Jett, M. et al., Tumoricidal Effects of Liposomes Containing Phosphatidylinositol or Phosphatidylcholine, Methods in Enzymology, vol. 141, pp. 459-466 (1987).
Woodle, M. et al., Liposome Preparation and Size Characterization, Methods in Enzymology, vol. 171, pp. 193-217 (1989).
Szoka, F. et al., Procedure for Preparation of Liposomes with Large Internal Aqueous Space and High Capture by Reverse-Phase Evaporation, Proc. Nat. Acad. Sci., vol. 75, 4194-4198. (Sep. 1978).
Gabizon, A. et al., Liposome Formulations with Prolonged Circulation Time in Blood and Enhanced Uptake by Tumors, Proc. Natl. Acad. Sci. 85, 6949-6953, Sep. 1988.
Papahadjopoulos et al., Sterically Stabilized Liposomes: Improvements in Pharmacokinetics and Antitumor Therapeutic Efficacy, Proc. Natl. Acad. Sci. 88, 11460-11464, Dec. 1991.
Shelly, K. et al., Model Studies Directed Toward the Boron Neutron-Capture Therapy of Cancer: Boron Delivery to Murine Tumors with Liposomes, Proc. Natl. Acad. Sci. vol. 89, 9039-9043, Oct. 1991.
Giovanella, B. et al., DNA Topoisomerase I-Targeted Chemotherapy of Human Colon Cancer in Xenografts, Science 246, 1046-1048, Nov. 24, 1989.
Josien, H. et al, Synthesis of (S)-Mappicine and Mappicine Ketone Via Radical Cascade Reaction of Isonitriles, Tetrahedron, 53, 8881-8886 (1997).
Jew et al., Synthesis and Antitumor Activity of 7-Substituted 20(RS)-Camptothecin Analogues, Bioorg. Med. Chem. Letters 6, 845-848.
Wang et al., Synthesis of Novel Water-Soluble 7-(aminoacylhydrazono) -formyl Camptothecins with Potent Inhibition of DNA Topo. I, Bioorg. Med. Chem. 2(12), 1397-1402 (1994).
Wang et al., Novel Water-Soluble 7-(acylhydrazono) -formyl Camptothecins as Potent Inhibitors of DNA Topo, I, Bioorg. Med. Chem. Lett. 4(4), 579-582 (1994).
Sawada et al., Chem. Mod. of an Antitumor Alkaloid Camptothecin: Synthesis and Antitumor Activity of 7-C-Sub. Camptothecs; Chem. Pharm. Bull. 39(10), 2574-80(1991).
Curran Dennis P.
Du Wu
Latus, legal representative Lori
Grazier Nyeemah
King & Schickli PLLC
Saeed Kamal A.
University of Kentucky Research Foundation
University of Pittsburg
LandOfFree
Highly lipophilic camptothecin intermediates and prodrugs... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Highly lipophilic camptothecin intermediates and prodrugs..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Highly lipophilic camptothecin intermediates and prodrugs... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3664674